selenocysteine has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, MZ; Fan, CD; Fu, XT; Fu, XY; Shao, LR; Sun, BL; Sun, JY; Yang, MF; Yang, XY; Zhang, HF; Zhang, ZY; Zhao, SJ | 1 |
| Fan, CD; Fu, XT; Fu, XY; Hou, YJ; Li, Y; Sun, BL; Sun, JY; Wang, K; Yang, MF; Yi, SY; Zhai, J | 1 |
2 other study(ies) available for selenocysteine and Glioma
| Article | Year |
|---|---|
Selenocysteine induces apoptosis in human glioma cells: evidence for TrxR1-targeted inhibition and signaling crosstalk.
Topics: Animals; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Line, Tumor; DNA Damage; Glioma; Humans; MAP Kinase Signaling System; Mice, Inbred BALB C; Mitochondria; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Selenocysteine; Signal Transduction; Thioredoxin Reductase 1; Xenograft Model Antitumor Assays | 2017 |
Induction of S-Phase Arrest in Human Glioma Cells by Selenocysteine, a Natural Selenium-Containing Agent Via Triggering Reactive Oxygen Species-Mediated DNA Damage and Modulating MAPKs and AKT Pathways.
Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; DNA Damage; Glioma; Humans; MAP Kinase Signaling System; Oncogene Protein v-akt; Reactive Oxygen Species; Selenium; Selenocysteine | 2016 |